Luciferase Firefly

Luciferin 4-Monooxygenase Firefly Recombinant
Shipped with Ice Packs
In Stock

Description

Biochemical Properties and Reaction Mechanism

Firefly luciferase (EC 1.13.12.7) is a 62 kDa enzyme comprising 550 amino acids. Its structure consists of two domains:

  • N-terminal domain: Contains a β-barrel and αβαβα layered structure.

  • C-terminal domain: Connected via a flexible hinge, forming the active-site cleft .

The reaction occurs in two steps:

  1. Adenylation:

    D-luciferin+ATPMg2+luciferyl-adenylate+PPi\text{D-luciferin} + \text{ATP} \xrightarrow{\text{Mg}^{2+}} \text{luciferyl-adenylate} + \text{PP}_i
  2. Oxidation:

    Luciferyl-adenylate+O2oxyluciferin+AMP+light(λmax=560nm)\text{Luciferyl-adenylate} + \text{O}_2 \rightarrow \text{oxyluciferin} + \text{AMP} + \text{light} \, (\lambda_{\text{max}} = 560 \, \text{nm})

Light emission arises from the excited-state oxyluciferin intermediate .

Key Reaction ParametersValues
ATP KmK_m (wild-type)0.13 mM
D-luciferin KmK_m (wild-type)0.06 mM
Optimal pH7.8–8.0

Spectral Diversity and Mutagenesis

Firefly luciferase exhibits color variation due to structural modifications:

  • Natural variants: Emissions range from yellow-green (firefly) to blue (sea pansy) .

  • Engineered mutants:

    • YY5 mutant: 8 amino acid substitutions enhance thermostability (25-fold longer half-life at 37°C) and catalytic efficiency (kcatk_{\text{cat}} increased 4-fold) .

    • LGR mutant: Shifts emission to red (640 nm) for multiplexed assays .

Regulatory Mechanisms

  • Substrate inhibition:

    • L-luciferin competitively inhibits D-luciferin oxidation (Ki=0.2μMK_i = 0.2 \, \mu\text{M}) .

  • Allosteric activation: ATP binding at two sites increases substrate affinity .

Applications in Biotechnology

ApplicationDescriptionExample
Gene expression reportingLuciferase linked to promoters for real-time transcriptional monitoring.pLX313-Firefly luciferase lentivirus
ATP quantificationDetects viable cells via ATP-dependent luminescence (sensitivity: 0.01 pmol ATP)ATP Cell Viability Assay
BiosensorsBRET (Bioluminescence Resonance Energy Transfer) for protein interactions.Mutant E (T214A, A215L, etc.)

Recent Research Advances

  • Luciferin regeneration: Identified acyl-CoA thioesterase (ACOT1) converting L- to D-luciferin in firefly lanterns .

  • Multicatalysis: Demonstrated fatty acyl-CoA synthesis activity, linking luciferase to metabolic pathways .

  • Thermostable mutants: Engineered variants (e.g., YY5) enable in vivo tumor imaging with enhanced signal persistence .

Product Specs

Introduction
Luciferase, an oxidative enzyme crucial for bioluminescence, catalyzes a reaction involving luciferin, Mg2+, and ATP to produce green light (562 nm). This enzyme, particularly from fireflies, finds widespread use in gene regulation and function studies, as well as pharmaceutical screening.
Description
This Escherichia coli-derived Luciferase is a single, non-glycosylated polypeptide chain with 571 amino acids (residues 1-550) and a molecular weight of 62.9 kDa. It includes a 21 amino acid His-tag at the N-terminus and is purified using proprietary chromatographic methods.
Physical Appearance
A clear, sterile-filtered liquid.
Formulation
This Luciferase protein solution (1 mg/ml) is supplied in a buffer containing 20 mM Tris-HCl (pH 8), 1 mM DTT, and 10% glycerol.
Stability
For short-term storage (2-4 weeks), keep at 4°C. For extended storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Minimize repeated freeze-thaw cycles.
Purity
Purity exceeds 90% as determined by SDS-PAGE analysis.
Synonyms
Luciferase-like monooxygenase, LUC, EC 1.13.12.7.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MMEDAKNIKK GPAPFYPLED GTAGEQLHKA MKRYALVPGT IAFTDAHIEV DITYAEYFEM SVRLAEAMKR YGLNTNHRIV VCSENSLQFF MPVLGALFIG VAVAPANDIY NERELLNSMG ISQPTVVFVS KKGLQKILNV QKKLPIIQKI IIMDSKTDYQ GFQSMYTFVT SHLPPGFNEY DFVPESFDRD KTIALIMNSS GSTGLPKGVA LPHRTACVRF SHARDPIFGN QIIPDTAILS VVPFHHGFGM FTTLGYLICG FRVVLMYRFE EELFLRSLQD YKIQSALLVP TLFSFFAKST LIDKYDLSNL HEIASGGAPL SKEVGEAVAK RFHLPGIRQG YGLTETTSAI LITPEGDDKP GAVGKVVPFF EAKVVDLDTG KTLGVNQRGE LCVRGPMIMS GYVNNPEATN ALIDKDGWLH SGDIAYWDED EHFFIVDRLK SLIKYKGYQV APAELESILL QHPNIFDAGV AGLPDDDAGE LPAAVVVLEH GKTMTEKEIV DYVASQVTTA KKLRGGVVFV DEVPKGLTGK LDARKIREIL IKAKKGGKIA V.

Q&A

What is the basic mechanism of firefly luciferase bioluminescence?

Firefly luciferase (FLuc) is a 62,000 Dalton monomeric protein that catalyzes the ATP-dependent oxidation of D-luciferin to oxyluciferin, producing light centered at 560 nm. This reaction occurs without requiring post-translational processing for enzymatic activity. The light emission is directly proportional to the number of luciferase molecules present, making it an excellent quantitative reporter system. The bioluminescent reaction fundamentally differs from fluorescence in that it's a chemical process where enzyme-catalyzed substrate breakdown directly produces light, rather than requiring external excitation .

What distinguishes flash vs. glow-type luciferase assay systems?

Luciferase assays come in two principal formats with distinct kinetic properties:

PropertyFlash-Type AssaysGlow-Type Assays
Signal intensityHigher initial brightnessLower but more consistent
Signal half-lifeApproximately 10 minutesSeveral hours (typically 2+ hours)
ApplicationBest for rapid, high-sensitivity measurementsPreferred for high-throughput screening, automated plate reading
WorkflowRequires immediate measurement after reagent additionAllows for greater flexibility in measurement timing

Flash-type assays produce a burst of light that decays relatively quickly, while glow-type assays sacrifice some intensity for substantially improved signal stability . The choice between these formats depends on experimental design requirements, instrumentation, and throughput needs.

How should researchers optimize transfection conditions for luciferase reporter assays?

When designing luciferase reporter experiments, transfection optimization is critical for reliable data. Researchers should:

  • Determine optimal DNA:transfection reagent ratios through preliminary calibration experiments

  • Maintain consistent cell density and passage number across experiments

  • Include appropriate controls: empty vector (negative), strong constitutive promoter (positive), and internal control reporter (normalization)

  • Consider co-transfecting with a second luciferase reporter (such as Renilla or NanoLuc) at a 10:1 to 50:1 ratio (experimental:control) for dual-luciferase normalization

  • Allow sufficient expression time (typically 24-48 hours) before performing assays

These optimization steps are essential since transfection efficiency variations can significantly impact apparent luciferase activity independent of the biological effect being studied .

What are the key considerations when selecting between different engineered firefly luciferase variants?

Researchers should consider several factors when choosing engineered luciferase variants:

Luciferase VariantHalf-lifeResponse TimeSignal IntensityBest Applications
luc23 hoursStandardHighestGeneral reporter assays, stable expression systems
luc2P1 hourFasterModerateTranscriptional dynamics, responsive elements
luc2CP0.4 hourRapidLowestFast-responding systems, transient stimuli
RapidResponse™<0.4 hourVery rapidVery lowReal-time monitoring of rapid cellular events

How can researchers effectively normalize luciferase reporter data to control for experimental variability?

Effective normalization strategies include:

  • Dual-reporter normalization: Co-transfection with control reporter (Renilla or NanoLuc luciferase) under a constitutive promoter allows division of experimental signal by control signal, correcting for transfection efficiency, cell number, and viability variations.

  • Protein concentration normalization: Normalizing to total protein can account for cell number variations, though this doesn't control for transfection efficiency.

  • Cell number normalization: Direct normalization to cell count or a separate viability assay.

  • Internal reference controls: Including known responsive and non-responsive elements as controls within each experiment.

Dual-reporter systems provide particularly robust normalization. For example, in the Nano-Glo® Dual-Luciferase® system, firefly luciferase activity is measured first, followed by quenching and subsequent measurement of NanoLuc® luciferase, creating an internal control for each sample .

How can researchers effectively use multiplex luciferase assays to examine multiple cellular pathways simultaneously?

Multiplex luciferase systems enable researchers to monitor multiple signaling pathways or gene expression events in the same cell population. Successful implementation requires:

  • Selection of orthogonal luciferases with distinct substrate preferences or separable emission spectra

  • Verification of minimal cross-interference between reporters

  • Consistent expression levels of control reporters

  • Mathematical computation to distinguish overlapping emissions when necessary

Key criteria for selecting luciferases for multiplexing include: substrate specificity, emission spectral separation, signal stability, and dynamic range. For example, a successful triple-luciferase system might combine firefly luciferase (D-luciferin substrate, 560 nm emission), Renilla luciferase (coelenterazine substrate, 480 nm emission), and NanoLuc (furimazine substrate, 460 nm emission) .

What approaches can identify and characterize red-shifting mutations in firefly luciferase?

The identification of red-shifting mutations is valuable for developing spectrally distinct reporters. Effective approaches include:

  • Deep mutational scanning: Systematically assessing multiple amino acid positions for spectral effects. Recent work has applied this technique to identify key residues affecting emission color .

  • Compensatory mutation analysis: Using a mutual compensation strategy where strongly green-shifting (Y35N) and red-shifting (H433Y) mutations can counterbalance each other. This approach has successfully identified strong red-shifting mutations like E457 modifications .

  • Structure-guided mutagenesis: Targeting residues within the luciferin binding pocket (within 5 Å of substrate). Studies have shown that 7 residues spanning Arg218-Ala348 produce substantial red-shifts when mutated .

  • Emission spectrum analysis: Careful measurement of full emission spectra rather than single wavelength intensities to accurately characterize spectral shifts.

These approaches have expanded our toolkit of spectrally distinct luciferases for multiplexed applications and advanced our understanding of the structural basis for bioluminescence color determination.

How can researchers develop photoactivatable luciferase systems for spatiotemporal control?

Photoactivatable firefly luciferase (pfLuc) provides precise spatiotemporal control over luciferase activity. Development strategies include:

  • Site-specific incorporation of photocaged amino acids at key catalytic residues (like Lys529)

  • Testing various photocaging groups for efficient uncaging and minimal background activity

  • Optimizing light sources and exposure parameters for activation

  • Validation in cellular contexts to ensure proper folding and activity post-uncaging

This approach has been used to create light-triggered luminescence gain, allowing researchers to measure intracellular ATP levels without disrupting cellular physiology. The photoinduced gain of luminescence also provides a method to assess photolysis efficiency of photosensitive amino acid analogues within carrier proteins both in vitro and in living cells .

What are the most common causes of poor signal-to-noise ratio in luciferase assays and how can they be addressed?

Poor signal-to-noise ratios can significantly impact experimental reliability. Common issues and solutions include:

ProblemPotential CausesSolutions
High backgroundPromoter leakiness, contamination, instrument noiseUse stringent promoter systems, freshly prepared reagents, optimize instrument settings
Low signalPoor transfection, low expression, improper cell lysisOptimize transfection, use codon-optimized reporters, ensure complete cell lysis
Signal variabilityInconsistent cell number, pipetting errorStandardize cell plating, use multichannel pipettes, include technical replicates
Rapid signal decayATP depletion, inhibitors in sampleUse glow-type reagents, optimize sample preparation to remove inhibitors

Additionally, using white opaque plates reduces well-to-well crosstalk and light absorption. For flash-type assays, consistent timing between reagent addition and measurement is crucial for reproducibility .

How should researchers interpret non-linear dose-response relationships in luciferase reporter assays?

When encountering non-linear dose-response relationships:

  • Verify assay linearity range: Luciferase assays typically have an extremely wide dynamic range (>8 orders of magnitude), but very high expression can exceed detector limits or substrate availability. Dilution series can determine the linear range of detection.

  • Consider biological explanations: Non-linear responses may reflect actual biological phenomena such as cooperative binding, feedback regulation, or threshold effects in signal transduction.

  • Check for technical limitations: Substrate depletion at high luciferase expression, detector saturation, or quenching effects can cause apparent non-linearity.

  • Examine enzyme kinetics: In some contexts, luciferase activity may follow Michaelis-Menten kinetics rather than linear relationships, particularly when substrate concentrations are limiting.

Proper controls and standard curves can help distinguish biological non-linearity from technical artifacts in dose-response experiments.

How are researchers utilizing deep mutational scanning to engineer firefly luciferase with novel properties?

Deep mutational scanning has emerged as a powerful approach for systematically exploring the sequence-function relationship in firefly luciferase. Recent applications include:

  • Comprehensive assessment of functionally important positions affecting spectral properties, particularly red-shifting mutations

  • Identification of mutations that enhance thermostability without compromising activity

  • Development of variants with altered substrate specificity or improved catalytic efficiency

  • Creation of luciferases with reduced pH sensitivity for applications in acidic cellular compartments

This approach allows researchers to systematically assess mutations at 20 functionally important amino acid positions, generating comprehensive datasets that reveal previously undiscovered sequence-function relationships .

What are the latest developments in using firefly luciferase for in vivo imaging applications?

Recent advances in firefly luciferase for in vivo imaging include:

  • Red-shifted variants that produce light at wavelengths with better tissue penetration (>600 nm)

  • Split-luciferase complementation systems for detecting protein-protein interactions in living animals

  • Engineered luciferase-luciferin pairs with improved pharmacokinetics and biodistribution

  • Combination with advanced imaging technologies such as cooled CCD cameras and tomographic reconstruction algorithms

These developments have expanded the utility of firefly luciferase for non-invasive tracking of cells, monitoring gene expression, and studying disease progression in living organisms with improved sensitivity and spatial resolution.

How can researchers leverage evolutionary approaches to develop novel luciferase variants with enhanced properties?

Evolutionary engineering approaches for luciferase development include:

  • Directed evolution: Using error-prone PCR and selection/screening for desired properties

  • DNA shuffling: Recombining gene fragments from related luciferases to generate chimeric enzymes

  • Ancestral sequence reconstruction: Inferring and synthesizing evolutionary ancestors as starting points for engineering

  • Computational protein design: Using structural information and algorithms to predict beneficial mutations

These approaches have yielded luciferases with enhanced thermostability, altered substrate specificity, improved expression in specific host organisms, and novel spectral properties. Combining evolutionary approaches with structure-guided design has proven particularly effective for developing luciferases with multiple improved properties.

Product Science Overview

Origin and Discovery

Firefly luciferase was first isolated from the common eastern firefly, Photinus pyralis. The enzyme’s ability to produce light through the oxidation of luciferin in the presence of ATP and oxygen has fascinated scientists for decades . The reaction produces a flash of yellow-green light with an emission peak around 560 nm .

Structure and Function

Firefly luciferase is a single polypeptide chain with a molecular weight of approximately 61 kDa . The enzyme catalyzes the oxidation of luciferin, a heterocyclic compound, to oxyluciferin, producing light in the process. This reaction requires ATP and magnesium ions (Mg²⁺) as cofactors .

The enzyme’s structure includes several key residues that are essential for its catalytic activity. These residues help in binding the substrate and stabilizing the reaction intermediates . The enzyme’s active site is highly conserved among different species of fireflies, indicating its evolutionary significance .

Preparation Methods

Recombinant firefly luciferase is typically produced using an Escherichia coli expression system . The gene encoding the luciferase enzyme is cloned into a plasmid vector, which is then introduced into E. coli cells. The bacteria are cultured, and the luciferase protein is expressed and purified using various chromatography techniques .

The recombinant enzyme is usually supplied in a buffered solution containing Tris-acetate, ammonium sulfate, glycerol, ethylene glycol, EDTA, and DTT . This preparation ensures the stability and activity of the enzyme during storage and use.

Chemical Reactions

The bioluminescent reaction catalyzed by firefly luciferase occurs in two main steps :

  1. Adenylation of Luciferin: Luciferin reacts with ATP to form luciferyl adenylate and pyrophosphate (PPi).
  2. Oxidation of Luciferyl Adenylate: The luciferyl adenylate complex reacts with molecular oxygen to produce oxyluciferin, AMP, CO₂, and light.

The light produced in this reaction is due to the formation of oxyluciferin in an electronically excited state, which then returns to its ground state by emitting a photon .

Applications

Firefly luciferase has become a widely used reporter protein in various biological assays. Its ability to produce light in a highly specific and quantifiable manner makes it an excellent tool for studying gene expression, cell viability, and ATP quantification . The enzyme’s bioluminescent properties have also been harnessed for in vivo imaging and other diagnostic applications .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.